Xiangrong Song

机构：Shihezi University, Sichuan University, Soochow University, West China Hospital of Sichuan University, Guangdong Provincial Occupational Disease Prevention Hospital, Frontier Science Foundation, State Key Laboratory of Biotherapy · ORCID：0000-0002-2853-2696

发表论文 207 篇 · 总被引 8136 次 · h-index 41

代表论文

• IRF5 siRNA Nanoimmunotherapy: Restoring Macrophage Efferocytosis in Atherosclerosis (2025 · Circulation · 被引 18)
• A precision-engineered dendritic cell-targeted mRNA nanovaccine for enhanced antiviral immunity (2025 · Cell Biomaterials · 被引 11)
• Intranasal vaccine combining adenovirus and trimeric subunit protein provides superior immunity against SARS-CoV-2 Omicron variant (2025 · Nature Biomedical Engineering · 被引 8)
• A novel dual-targeting strategy of nanobody-driven protein corona modulation for glioma therapy (2025 · Acta Pharmaceutica Sinica B · 被引 8)
• Reprogramming Lesional Macrophage Homeostasis via Interferon Regulatory Factor 5 Targeted siRNA Nanoimmunotherapy for Atherosclerosis (2026 · ACS Nano · 被引 7)
• Multifunctional Inorganic-Nanosheets-Based Nanohydrogel for Periodontal Bone Regeneration via Antibacterial and Anti-Ferroptotic Immunomodulation (2025 · ACS Applied Materials & Interfaces · 被引 7)